Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
INCY > SEC Filings for INCY > Form 8-K on 15-Nov-2012All Recent SEC Filings

Show all filings for INCYTE CORP

Form 8-K for INCYTE CORP


Other Events

Item 8.01 Other Events.

On November 15, 2012, Incyte Corporation (the "Company") announced that it had earned a $50.0 million milestone payment pursuant to the License, Development and Commercialization Agreement dated as of December 18, 2009, by and between the Company and Eli Lilly and Company. Achievement of the milestone payment was related to the initiation of the Phase III program for baricitinib (LY3009104) for the treatment of rheumatoid arthritis.

  Add INCY to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for INCY - All Recent SEC Filings
Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.